Early application of a standardized skin care product does not prevent atopic dermatitis in predisposed infantsNovember 18, 2022Atopic Dermatitis
Topical POLG nanoemulsion improves dryness and itchiness in atopic dermatitisNovember 18, 2022Atopic Dermatitis
Emollient use in the first year of life does not protect against atopic dermatitis in the long termNovember 18, 2022Atopic Dermatitis
Topical prebiotics and postbiotics effective and well tolerated in mild-to-moderate atopic dermatitisNovember 18, 2022Atopic Dermatitis
Atopic dermatitis patients with good clinical response or conjunctivitis may opt for longer dupilumab dosing intervalNovember 18, 2022Atopic Dermatitis
Long-term efficacy of baricitinib in moderate-to-severe atopic dermatitisNovember 18, 2022Atopic Dermatitis
Long-term efficacy of baricitinib in moderate-to-severe atopic dermatitisNovember 18, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: No increased infection risk with long-term dupilumab useNovember 18, 2022Atopic Dermatitis
Exposure to wildfire air pollution increases atopic dermatitis risk in older adultsNovember 18, 2022Atopic Dermatitis
Atopic dermatitis: Dupilumab serum levels not associated with treatment response or adverse effectsNovember 18, 2022Atopic Dermatitis
Dermatology NewsSerum dupilumab levels do not predict clinical responseNovember 11, 2022Atopic DermatitisPediatrics
Dermatology NewsBreaking the itch-scratch cycle with mindfulnessNovember 10, 2022Contact DermatitisMixed TopicsAtopic DermatitisPediatrics
Past, Present, and Future of Pediatric Atopic Dermatitis ManagementNovember 4, 2022Atopic DermatitisPediatrics
Dermatology NewsRapid action or sustained effect? Methotrexate vs. ciclosporin for pediatric ADNovember 2, 2022Atopic DermatitisPediatrics
